. Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer". J Clin Endocrinol Metab 2025 Mar 27:dgaf185. doi: 10.1210.
PMID: 40152435